Shukra Pharma.

{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "55.55",
    "chg": 1.61,
    "chgp": "2.98%",
    "dir": 1,
    "prev_price": "53.94",
    "mcapval": "2,401.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "SHUKRAPHAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE551C01044",
    "curr_date": "Sep 15, 04:01 PM",
    "curr_time": "17:04 PM",
    "last_traded_at": "Sep 15, 04:01 PM IST",
    "bse_nse_vol": "2.31 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 15, 2026",
    "traded_date_str": "2026 09 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Shukra Pharmaceuticals Gains 3.81%: 3 Key Factors Driving the Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-gains-381-3-key-factors-driving-the-move-4191585",
        "imagepath": "",
        "date": "2026-09-12 16:02:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>7 Sep:</strong> Stock opens at Rs.53.07, rising 2.14% despite Sensex decline</p>\n                    <p><strong>10 Sep:</strong> Formation of Golden Cross signals potential bullish breakout</p>\n                    <p><strong>10 Sep:</strong> Mojo Grade upgraded from Hold to Buy on strong fundamentals</p>\n                    <p><strong>11 Sep:</strong> Technical momentum shifts to bullish despite minor price dip</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.51.96</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</..."
      },
      {
        "title": "Shukra Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4189909",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4189909.png",
        "date": "2026-09-11 08:10:01",
        "description": "Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly results, impressive long-term growth, and a shift to a bullish technical outlook, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4189758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4189758.png",
        "date": "2026-09-11 08:02:20",
        "description": "Shukra Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a bullish trajectory. Despite a recent day decline of 4.23%, the stock’s technical indicators reveal a complex but predominantly positive outlook, supported by strong moving averages and bullish signals on weekly charts. This analysis delves into the key technical parameters shaping investor sentiment and the stock’s potential trajectory in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Golden Cross Forms in Shukra Pharmaceuticals Ltd — On a Day the Stock Fell 4.2%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4189645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_goldencross_4189645.png",
        "date": "2026-09-10 18:00:37",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Shukra Pharmaceuticals Ltd, signalling a golden cross on 10 Sep 2026. Yet, the stock declined 4.23% on the same day, while monthly momentum indicators remain mildly bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal’s reliability."
      },
      {
        "title": "Shukra Pharmaceuticals Surges 17.34%: Key Technical Shifts and Financials Drive Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-surges-1734-key-technical-shifts-and-financials-drive-rally-4183887",
        "imagepath": "",
        "date": "2026-09-05 17:07:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Stock opens at Rs.44.43 with mild bullish momentum</p>\n                    <p><strong>1 Sep:</strong> MarketsMOJO downgrades rating to Sell amid mixed technicals</p>\n                    <p><strong>2 Sep:</strong> Technical momentum shifts to mildly bearish; cautious trading</p>\n                    <p><strong>3 Sep:</strong> Strong price rally of 11.13%, technical momentum turns mildly bullish</p>\n                    <p><strong>4 Sep:</strong> MarketsMOJO upgrades rating to Hold; stock closes at Rs.51.96</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"s..."
      },
      {
        "title": "Shukra Pharmaceuticals Upgraded to Hold as Financials and Technicals Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-upgraded-to-hold-as-financials-and-technicals-improve-4181945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4181945.png",
        "date": "2026-09-04 08:08:05",
        "description": "Shukra Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a significant improvement in its financial performance and a nuanced shift in technical indicators. Despite a premium valuation, the company’s robust growth metrics and recent positive quarterly results have prompted a reassessment of its outlook, balancing quality, valuation, financial trends, and technical factors."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-strong-price-rally-4181774",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4181774.png",
        "date": "2026-09-04 08:02:17",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a significant 11.13% gain on 4 Sep 2026, lifting the stock price to ₹52.00 from the previous close of ₹46.79. This surge accompanies a technical parameter change that has altered the stock’s momentum profile from mildly bullish to sideways, prompting a reassessment of its technical indicators and market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4180285",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4180285.png",
        "date": "2026-09-03 08:02:31",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend as of early September 2026. Despite a micro-cap classification and a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators reveal a complex picture that investors should carefully analyse."
      },
      {
        "title": "Shukra Pharmaceuticals Downgraded to Sell Amid Mixed Technicals and Expensive Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-downgraded-to-sell-amid-mixed-technicals-and-expensive-valuation-4178950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4178950.png",
        "date": "2026-09-02 08:26:42",
        "description": "Shukra Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell as of 1 September 2026, driven primarily by a shift in technical indicators and valuation concerns despite strong financial performance. The micro-cap pharmaceutical company’s Mojo Score has declined to 47.0, reflecting a more cautious stance amid mixed signals across quality, valuation, financial trends, and technicals."
      }
    ],
    "total": 670,
    "sid": "505931",
    "stock_news_url": "https://www.marketsmojo.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "05-Sep-2026",
      "details": "ANNUAL REPORT",
      "source": "BSE"
    },
    {
      "caption": "AGM NOTICE",
      "datetime": "05-Sep-2026",
      "details": "AGM NOTICE",
      "source": "BSE"
    },
    {
      "caption": "Update On Date Of AGM",
      "datetime": "03-Sep-2026",
      "details": "Update on Date of AGM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 21 Sep 26",
          "dt": "2026-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shukra Pharmaceuticals Gains 3.81%: 3 Key Factors Driving the Move

2026-09-12 16:02:46

Key Events This Week

7 Sep: Stock opens at Rs.53.07, rising 2.14% despite Sensex decline

10 Sep: Formation of Golden Cross signals potential bullish breakout

10 Sep: Mojo Grade upgraded from Hold to Buy on strong fundamentals

11 Sep: Technical momentum shifts to bullish despite minor price dip

Week Open

Rs.51.96

Week CloseRead full news article

Shukra Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals

2026-09-11 08:10:01

Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly results, impressive long-term growth, and a shift to a bullish technical outlook, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-11 08:02:20

Shukra Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a bullish trajectory. Despite a recent day decline of 4.23%, the stock’s technical indicators reveal a complex but predominantly positive outlook, supported by strong moving averages and bullish signals on weekly charts. This analysis delves into the key technical parameters shaping investor sentiment and the stock’s potential trajectory in the Pharmaceuticals & Biotechnology sector.

Read full news article

Golden Cross Forms in Shukra Pharmaceuticals Ltd — On a Day the Stock Fell 4.2%. What the Mixed Signals Mean

2026-09-10 18:00:37

The 50-day moving average has crossed above the 200-day moving average for Shukra Pharmaceuticals Ltd, signalling a golden cross on 10 Sep 2026. Yet, the stock declined 4.23% on the same day, while monthly momentum indicators remain mildly bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal’s reliability.

Read full news article

Shukra Pharmaceuticals Surges 17.34%: Key Technical Shifts and Financials Drive Rally

2026-09-05 17:07:53

Key Events This Week

31 Aug: Stock opens at Rs.44.43 with mild bullish momentum

1 Sep: MarketsMOJO downgrades rating to Sell amid mixed technicals

2 Sep: Technical momentum shifts to mildly bearish; cautious trading

3 Sep: Strong price rally of 11.13%, technical momentum turns mildly bullish

4 Sep: MarketsMOJO upgrades rating to Hold; stock closes at Rs.51.96

Week Open

Read full news article

Shukra Pharmaceuticals Upgraded to Hold as Financials and Technicals Improve

2026-09-04 08:08:05

Shukra Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a significant improvement in its financial performance and a nuanced shift in technical indicators. Despite a premium valuation, the company’s robust growth metrics and recent positive quarterly results have prompted a reassessment of its outlook, balancing quality, valuation, financial trends, and technical factors.

Read full news article

Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Strong Price Rally

2026-09-04 08:02:17

Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a significant 11.13% gain on 4 Sep 2026, lifting the stock price to ₹52.00 from the previous close of ₹46.79. This surge accompanies a technical parameter change that has altered the stock’s momentum profile from mildly bullish to sideways, prompting a reassessment of its technical indicators and market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-09-03 08:02:31

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend as of early September 2026. Despite a micro-cap classification and a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators reveal a complex picture that investors should carefully analyse.

Read full news article

Shukra Pharmaceuticals Downgraded to Sell Amid Mixed Technicals and Expensive Valuation

2026-09-02 08:26:42

Shukra Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell as of 1 September 2026, driven primarily by a shift in technical indicators and valuation concerns despite strong financial performance. The micro-cap pharmaceutical company’s Mojo Score has declined to 47.0, reflecting a more cautious stance amid mixed signals across quality, valuation, financial trends, and technicals.

Read full news article

View All News